| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Dr. Saslow is Director, Breast and Gynecologic Cancer, Cancer Control Science Department, American Cancer Society, Atlanta, GA.
Dr. Boetes is Professor, Department of Radiology, University Medical Center Nijmegen, Nijmegen, The Netherlands.
Dr. Burke is Chair; and Professor of Medical History and Ethics, University of Washington, Seattle, WA.
Dr. Harms is Radiologist, The Breast Center of Northwest Arkansas, Fayetteville, AR; and Clinical Professor of Radiology, University of Arkansas for Medical Sciences, Little Rock, AR.
Dr. Leach is Professor of Physics as Applied to Medicine; Co-Chairman, Section of Magnetic Resonance; and Co-Director, Cancer Research; UK Clinical Magnetic Resonance Research Group, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Surrey, UK.
Dr. Lehman is Professor of Radiology; and Section Head of Breast Imaging, University of Washington Medical Center and the Seattle Cancer Care Alliance, Seattle, WA.
Dr. Morris is Director, Breast MRI, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY.
Dr. Pisano is Vice Dean for Academic Affairs; Kenan Professor of Radiology and Biomedical Engineering; and Director, UNC Biomedical Research Imaging Center, UNC School of Medicine, University of North Carolina, Chapel Hill, NC.
Dr. Schnall is Matthew J. Wilson Professor of Radiology; and Associate Chair for Research, Department of Radiology, University of Pennsylvania, Philadelphia, PA.
Dr. Sener is Vice Chairman, Department of Surgery, Evanston Northwestern Health Care, Evanston, IL; and Professor of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL.
Dr. Smith is Director, Cancer Screening, Cancer Control Science Department, American Cancer Society, Atlanta, GA.
Dr. Warner is Associate Professor, Department of Medicine, University of Toronto and Toronto-Sunnybrook Regional Cancer Centre, Toronto, Canada.
Dr. Yaffe is Senior Scientist, Imaging Research, Sunnybrook Health Sciences Centre; and Professor, Departments of Medical Imaging and Medical Biophysics, University of Toronto, Toronto, Canada.
Ms. Andrews is Research Associate, Cancer Control Science Department, American Cancer Society, Atlanta, GA.
Dr. Russell is Associate Professor of Medicine, Keck School of Medicine, University of Southern California; and Co-Director of USC/Norris Breast Center, Los Angeles, CA.
This article is available online at http://CAonline.AmCancerSoc.org
To earn free CME credit for successfully completing the online quiz based on this article, go to http://CME.AmCancerSoc.org.
New evidence on breast Magnetic Resonance Imaging (MRI) screening has become available since the American Cancer Society (ACS) last issued guidelines for the early detection of breast cancer in 2003. A guideline panel has reviewed this evidence and developed new recommendations for women at different defined levels of risk. Screening MRI is recommended for women with an approximately 20–25% or greater lifetime risk of breast cancer, including women with a strong family history of breast or ovarian cancer and women who were treated for Hodgkin disease. There are several risk subgroups for which the available data are insufficient to recommend for or against screening, including women with a personal history of breast cancer, carcinoma in situ, atypical hyperplasia, and extremely dense breasts on mammography. Diagnostic uses of MRI were not considered to be within the scope of this review.
This article has been cited by other articles:
|
|
 |
|
  J. W. Gorechlad, E. B. McCabe, J. H. Higgins, D. S. Likosky, P. J. Lewis, K. M. Rosenkranz, and R. J. Barth Jr Screening for Recurrences in Patients Treated with Breast-Conserving Surgery: Is there a Role for MRI? Ann. Surg. Oncol., June 1, 2008; 15(6): 1703 - 1709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Hall The Rise and Impending Decline of Screening Mammography Radiology, June 1, 2008; 247(3): 597 - 601. [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Berg, J. D. Blume, J. B. Cormack, E. B. Mendelson, D. Lehrer, M. Bohm-Velez, E. D. Pisano, R. A. Jong, W. P. Evans, M. J. Morton, et al. Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer JAMA, May 14, 2008; 299(18): 2151 - 2163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Kuhl The "Coming of Age" of Nonmammographic Screening for Breast Cancer JAMA, May 14, 2008; 299(18): 2203 - 2205. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Warner, H. Messersmith, P. Causer, A. Eisen, R. Shumak, and D. Plewes Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer Ann Intern Med, May 6, 2008; 148(9): 671 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Pories, D. Zurakowski, R. Roy, C. C. Lamb, S. Raza, A. Exarhopoulos, R. G. Scheib, S. Schumer, C. Lenahan, V. Borges, et al. Urinary Metalloproteinases: Noninvasive Biomarkers for Breast Cancer Risk Assessment Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1034 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 BRCA Screening Obstet. Gynecol., May 1, 2008; 111(5): 1205 - 1206. [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Smith, V. Cokkinides, and O. W. Brawley Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues CA Cancer J Clin, May 1, 2008; 58(3): 161 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Offit Genomic Profiles for Disease Risk: Predictive or Premature? JAMA, March 19, 2008; 299(11): 1353 - 1355. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Tice, S. R. Cummings, R. Smith-Bindman, L. Ichikawa, W. E. Barlow, and K. Kerlikowske Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model Ann Intern Med, March 4, 2008; 148(5): 337 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Chlebowski, G. Anderson, M. Pettinger, D. Lane, R. D. Langer, M. A. Gillian, B. W. Walsh, C. Chen, A. McTiernan, and for the Women's Health Initiative Investigators Estrogen Plus Progestin and Breast Cancer Detection by Means of Mammography and Breast Biopsy Arch Intern Med, February 25, 2008; 168(4): 370 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Orel Who Should Have Breast Magnetic Resonance Imaging Evaluation? J. Clin. Oncol., February 10, 2008; 26(5): 703 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yu, A. Park, E. Morris, L. Liberman, P. I. Borgen, and T. A. King MRI Screening in a Clinic Population with a Family History of Breast Cancer Ann. Surg. Oncol., February 1, 2008; 15(2): 452 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Friedman, A. Rovo, W. Leisenring, A. Locasciulli, M. E. D. Flowers, A. Tichelli, J. E. Sanders, H. J. Deeg, and G. Socie Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party Blood, January 15, 2008; 111(2): 939 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gralow, R. F. Ozols, D. F. Bajorin, B. D. Cheson, H. M. Sandler, E. P. Winer, J. Bonner, G. D. Demetri, W. Curran Jr, P. A. Ganz, et al. Clinical Cancer Advances 2007: Major Research Advances in Cancer Treatment, Prevention, and Screening A Report From the American Society of Clinical Oncology J. Clin. Oncol., January 10, 2008; 26(2): 313 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Wollins and M. R. Somerfield Q and A: Magnetic Resonance Imaging in the Detection and Evaluation of Breast Cancer J. Oncol. Pract, January 1, 2008; 4(1): 18 - 23. [Full Text] [PDF]
|
|
|
|
|
|
A. N.A. Tosteson, N. K. Stout, D. G. Fryback, S. Acharyya, B. A. Herman, L. G. Hannah, E. D. Pisano, and for the DMIST Investigators Cost-Effectiveness of Digital Mammography Breast Cancer Screening Ann Intern Med, January 1, 2008; 148(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lee, M. Pintilie, D. C. Hodgson, P. E. Goss, and M. Crump Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma Ann. Onc., January 1, 2008; 19(1): 62 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Ng Second Cancers after Hodgkin's Lymphoma: Long-term Risks ASCO Educational Book, January 1, 2008; 2008(1): 418 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Schnipper Update in Oncology Ann Intern Med, December 4, 2007; 147(11): 775 - 782. [Full Text] [PDF]
|
|
|
|
|
|
S. C. Willey and C. Cocilovo Screening and Follow-up of the Patient at High Risk for Breast Cancer Obstet. Gynecol., December 1, 2007; 110(6): 1404 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Riedl, L. Ponhold, D. Flory, M. Weber, R. Kroiss, T. Wagner, M. Fuchsjager, and T. H. Helbich Magnetic Resonance Imaging of the Breast Improves Detection of Invasive Cancer, Preinvasive Cancer, and Premalignant Lesions during Surveillance of Women at High Risk for Breast Cancer Clin. Cancer Res., October 15, 2007; 13(20): 6144 - 6152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Burke and B. M. Psaty Personalized Medicine in the Era of Genomics JAMA, October 10, 2007; 298(14): 1682 - 1684. [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Causer, R. A. Jong, E. Warner, K. Hill, J. W. Wong, B. N. Curpen, and D. B. Plewes Breast Cancers Detected with Imaging Screening in the BRCA Population: Emphasis on MR Imaging with Histopathologic Correlation RadioGraphics, October 1, 2007; 27(suppl_1): S165 - S182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Stanwell and C. Mountford In Vivo Proton MR Spectroscopy of the Breast RadioGraphics, October 1, 2007; 27(suppl_1): S253 - S266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Gemignani Breast Cancer Screening for Women 40 to 49 Years of Age: What Is a Clinician to Do? Obstet. Gynecol., September 1, 2007; 110(3): 548 - 549. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Robson and K. Offit Management of an Inherited Predisposition to Breast Cancer N. Engl. J. Med., July 12, 2007; 357(2): 154 - 162. [Full Text] [PDF]
|
|
|
|
|
|
I. Garrido-Laguna, O. Fernandez Hidalgo, J. Garcia Foncillas, D. Gyorki, B. Mann, F. Frauscher, K. J. Sweeney, V. Sacchini, I. Nash, P. M. Marcus, et al. MRI Evaluation of Breast Cancer N. Engl. J. Med., July 12, 2007; 357(2): 191 - 193. [Full Text] [PDF]
|
|
|
|
|
|
N. D. Kauff and K. Offit Modeling Genetic Risk of Breast Cancer JAMA, June 20, 2007; 297(23): 2637 - 2639. [Full Text] [PDF]
|
|
|
|
|
|
D. F. Hayes Follow-up of Patients with Early Breast Cancer N. Engl. J. Med., June 14, 2007; 356(24): 2505 - 2513. [Full Text] [PDF]
|
|
|
|
 |
|
 Breast Cancer Screening with MRI Journal Watch (General), April 12, 2007; 2007(412): 1 - 1. [Full Text]
|
|
|
|
|
|
R. A. Smith, V. Cokkinides, and H. J. Eyre Cancer Screening in the United States, 2007: A Review of Current Guidelines, Practices, and Prospects CA Cancer J Clin, March 1, 2007; 57(2): 90 - 104. [Abstract] [Full Text] [PDF]
|
|
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
